Vedang Murthy

8.1k total citations · 1 hit paper
182 papers, 3.3k citations indexed

About

Vedang Murthy is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Otorhinolaryngology. According to data from OpenAlex, Vedang Murthy has authored 182 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Pulmonary and Respiratory Medicine, 81 papers in Surgery and 59 papers in Otorhinolaryngology. Recurrent topics in Vedang Murthy's work include Head and Neck Cancer Studies (59 papers), Advanced Radiotherapy Techniques (44 papers) and Prostate Cancer Diagnosis and Treatment (43 papers). Vedang Murthy is often cited by papers focused on Head and Neck Cancer Studies (59 papers), Advanced Radiotherapy Techniques (44 papers) and Prostate Cancer Diagnosis and Treatment (43 papers). Vedang Murthy collaborates with scholars based in India, United States and United Kingdom. Vedang Murthy's co-authors include Tejpal Gupta, Sarbani Ghosh Laskar, Ashwini Budrukkar, Jai Prakash Agarwal, Sadhana Kannan, Jaiprakash Agarwal, Venkatesh Rangarajan, Pankaj Chaturvedi, Zubin Master and Ketayun A. Dinshaw and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Neurology.

In The Last Decade

Vedang Murthy

164 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial

2021 176 citations Vedang Murthy, Priyamvada Maitre et al. profile →

Peers

Countries citing papers authored by Vedang Murthy

Since Specialization

Citations

This map shows the geographic impact of Vedang Murthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vedang Murthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vedang Murthy more than expected).

Fields of papers citing papers by Vedang Murthy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vedang Murthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vedang Murthy. The network helps show where Vedang Murthy may publish in the future.

Co-authorship network of co-authors of Vedang Murthy

This figure shows the co-authorship network connecting the top 25 collaborators of Vedang Murthy. A scholar is included among the top collaborators of Vedang Murthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vedang Murthy. Vedang Murthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Acute enteritis with pelvic SBRT: Influence of bowel delineation methods 2025 ·Clinical and Translational Radiation Oncology ·(unknown), Maneesh Singh, (unknown), Priyamvada Maitre, Vedang Murthy	2
2	Prospective comparative study of quality of life in patients with bladder cancer undergoing cystectomy with ileal conduit or bladder preservation 2024 ·SHILAP Revista de lepidopterología ·Vedang Murthy, (unknown), Mahendra Pal, (unknown), Priyamvada Maitre, Amandeep Arora, (unknown), Amit Joshi, (unknown), Gagan Prakash	1
3	Use of Focal Radiotherapy Boost for Prostate Cancer and Perceived Barriers toward its Implementation: A Survey 2023 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Asona Lui, Matthew S. Katz, Alejandro Berlín, (unknown), Amar U. Kishan, Vedang Murthy, Himanshu Nagar, (unknown), (unknown), Alison Tree, (unknown)	2
4	Utilising alternative cystoscopic schedules to minimise cost and patient burden after trimodality therapy for muscle‐invasive bladder cancer 2023 ·Cancer Medicine ·Rahul Krishnatry, Priyamvada Maitre, (unknown), (unknown), Ganesh Bakshi, Gagan Prakash, Mahendra Pal, Amit Joshi, Santosh Menon, Vedang Murthy	2
5	Imaging Recommendations for Diagnosis, Staging, and Management of Penile Cancer 2023 ·Indian Journal of Medical and Paediatric Oncology ·(unknown), (unknown), Palak Popat, Nilesh Sable, (unknown), (unknown), Archi Agrawal, Gagan Prakash, Vedang Murthy, Santosh Menon, Amit Joshi, (unknown), Suyash Kulkarni	0
6	Stereotactic Radiotherapy after Radical Prostatectomy in Patients with Prostate Cancer in the Adjuvant or Salvage Setting: A Systematic Review 2022 ·Cancers ·Christina Schröder, (unknown), Paul Windisch, Daniel R. Zwahlen, André Buchali, (unknown), Tilman Bostel, Tanja Sprave, Thomas Zilli, Vedang Murthy, Robert Förster	15
7	Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: A Systematic Review 2021 ·Cancers ·Robert Foerster, Daniel R. Zwahlen, André Buchali, (unknown), (unknown), Paul Windisch, (unknown), Sati Akbaba, Tilman Bostel, Tanja Sprave, Constantinos Zamboglou, Thomas Zilli, Jean‐Jacques Stelmes, (unknown), Vedang Murthy	22
8	Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients 2021 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Naomi Jiang, Donald B. Fuller, Andrew Loblaw, (unknown), Alan J. Katz, Sean P. Collins, Nima Aghdam, Simeng Suy, Kevin L. Stephans, Ye Yuan, Nicholas G. Nickols, Vedang Murthy, (unknown), Patrick A. Kupelian, Michael L. Steinberg, Tahmineh Romero, Amar U. Kishan	40
9	Post-cricoid and Upper Oesophagus Cancers Treated with Organ Preservation Using Intensity-modulated Image-guided Radiotherapy: a Phase II Prospective Study of Outcomes, Toxicity and Quality of Life 2021 ·Clinical Oncology ·Sarbani Ghosh Laskar, Shwetabh Sinha, Maneesh Singh, Naveen Mummudi, (unknown), (unknown), Ashwini Budrukkar, Monali Swain, J.P. Agarwal, Tejpal Gupta, Vedang Murthy, Smruti Mokal, Vijay Patil, Vanita Noronha, Amit Joshi, Nandini Menon, Kumar Prabhash	0
10	Pilot study comparing dominant intraprostatic lesion volume using Ga-68 prostate-specific membrane antigen PET-computed tomography and multiparametric MRI 2020 ·Nuclear Medicine Communications ·(unknown), Vedang Murthy, (unknown), Archi Agarwal, (unknown), (unknown), (unknown), Palak Popat	4
11	Submandibular function recovery after IMRT in head and neck cancer: A prospective dose modelling study 2018 ·Radiotherapy and Oncology ·Vedang Murthy, Shirley Lewis, Sadhana Kannan, (unknown), Venkatesh Rangarajan, (unknown), (unknown), (unknown), (unknown), Ashwini Budrukkar, Tejpal Gupta, Sarbani Ghosh Laskar, Jai Prakash Agarwal	13
12	Kidney cancer demographics and outcome data from 2013 at a tertiary cancer hospital in India 2017 ·Indian Journal of Cancer ·Gagan Prakash, Amit Joshi, Amitesh Anand, Kumar Prabhash, Vanita Noronha, (unknown), Ganesh Bakshi, Mahendra Pal, Vedang Murthy, Rahul Krishnatry, Sangeeta Desai, Santosh Menon, (unknown), Sheetal Kulkarni, Nilesh Sable, Palak Popat, Archi Agrawal, Venkatesh Rangarajan	13
13	The Rationale for Post-Operative Radiation in Localized Bladder Cancer 2017 ·Bladder Cancer ·Brian C. Baumann, Paul Sargos, Libni Eapen, Jason A. Efstathiou, Ananya Choudhury, Amit Bahl, Vedang Murthy, Leslie K. Ballas, Valérie Fonteyne, Pierre Richaud, Mohamed S. Zaghloul, John P. Christodouleas	19
14	Clinical Outcomes With Dose-Escalated Adaptive Radiation Therapy for Urinary Bladder Cancer: A Prospective Study 2015 ·International Journal of Radiation OncologyBiologyPhysics ·Vedang Murthy, (unknown), (unknown), Umesh Mahantshetty, Ganesh Bakshi, Gagan Prakash, Amit Joshi, Kumar Prabhash, (unknown), Shyam Kishore Shrivastava	29
15	Is there a role of induction chemotherapy followed by resection in T4b oral cavity cancers? 2013 ·Indian Journal of Cancer ·Kumar Prabhash, Amit Joshi, (unknown), Vanita Noronha, S Juvekar, Anuja Deshmukh, (unknown), (unknown), JP Agarwal, Sunita Ghosh, Vedang Murthy, Anil D’Cruz	38
16	Hypofractionated Radiotherapy for T1N0M0 Glottic Cancer: Retrospective Analysis of Two Different Cohorts of Dose-fractionation Schedules from a Single Institution 2012 ·Clinical Oncology ·(unknown), (unknown), Vedang Murthy, (unknown), (unknown), Tejpal Gupta, Jai Prakash Agarwal	13
17	‘Plan of the day’ adaptive radiotherapy for bladder cancer using helical tomotherapy 2011 ·Radiotherapy and Oncology ·Vedang Murthy, Zubin Master, (unknown), Indranil Mallick, Umesh Mahantshetty, Ganesh Bakshi, Hemant Tongaonkar, Shyam Kishore Shrivastava	68
18	Dose variation during hypofractionated image-guided radiotherapy for prostate cancer: Planned versus delivered 2011 ·Journal of Cancer Research and Therapeutics ·Vedang Murthy, Pragya Shukla, (unknown), Zubin Master, Umesh Mahantshetty, (unknown)	15
19	Skin dose measurements using MOSFET and TLD for head and neck patients treated with tomotherapy 2009 ·Applied Radiation and Isotopes ·(unknown), Vedang Murthy, (unknown), (unknown), (unknown), Deepak D. Deshpande	25
20	Time trial: A prospective comparative study of the time-resource burden for three-dimensional conformal radiotherapy and intensity-modulated radiotherapy in head and neck cancers 2009 ·Journal of Cancer Research and Therapeutics ·Vedang Murthy, Tejpal Gupta, (unknown), Sarbani Ghosh Laskar, Ashwini Budrukkar, (unknown), (unknown), Jaiprakash Agarwal	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact